You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

telaprevir

Showing 1 - 25 of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Telaprevir
  • +2 more
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Hepatitis C Infection, Depression Trial in Netherlands (Paroxetine, telaprevir)

Terminated
  • Hepatitis C Infection
  • Depression
  • Amsterdam, Netherlands
  • +6 more
Dec 4, 2020

Infection Trial in Houston (Pegylated Interferon Alfa 2a, Ribavirin, Telaprevir)

Terminated
Has Results
  • Infection
  • Pegylated Interferon Alfa 2a
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020

Chronic Hepatitis C Virus Infection Trial in New Zealand, United States (telaprevir, VX-222, ribavirin)

Terminated
  • Chronic Hepatitis C Virus Infection
  • telaprevir
  • +3 more
  • La Jolla, California
  • +20 more
Sep 22, 2020

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Telaprevir
  • +10 more
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C Trial in Worldwide (telaprevir, ribavirin, peginterferon alfa-2a)

Completed
Has Results
  • Hepatitis C
  • telaprevir
  • +2 more
  • Birmingham, Alabama
  • +81 more
Mar 3, 2021

Hepatitis C Virus Trial in Worldwide (Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • Peginterferon Lambda-1a
  • +3 more
  • Birmingham, Alabama
  • +103 more
Jul 29, 2019

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Telaprevir)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +3 more
  • (no location specified)
May 2, 2018

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Pegylated Interferon a-2a (PegINF))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +3 more
  • (no location specified)
May 2, 2018

Thrombocytopaenia Trial in Baltimore (Eltrombopag, Boceprevir, Telaprevir)

Completed
  • Thrombocytopaenia
  • Baltimore, Maryland
    GSK Investigational Site
Nov 8, 2017

Thrombocytopenia Trial in Los Angeles, Fairfax (Avatrombopag, Placebo, Pegylated interferon (PEG-IFN))

Completed
Has Results
  • Thrombocytopenia
  • Los Angeles, California
  • +1 more
Jan 25, 2018

Hepatitis C Trial in Atlanta, Burlington (Peginterferon alfa-2a, Ribavirin, telaprevir)

Withdrawn
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Atlanta, Georgia
  • +1 more
May 5, 2017

Hepatitis C, Chronic, Cirrhosis Trial in Cleveland (Telaprevir, Boceprevir, Peg-IFN)

Completed
  • Hepatitis C, Chronic
  • Cirrhosis
  • Telaprevir
  • +3 more
  • Cleveland, Ohio
    Louis Stokes Cleveland VA medical center
Mar 13, 2017

HIV Trial in London (Ribavirin, Telaprevir)

Completed
  • HIV
  • London, United Kingdom
    St Stephens AIDS Trust
Apr 10, 2017

Hepatitis C Trial in Worldwide (Ribavirin, Mericitabine, Peginterferon Alfa-2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +38 more
Apr 21, 2017

Hepatitis C, Chronic Trial in Worldwide (Telaprevir)

Completed
  • Hepatitis C, Chronic
  • Telaprevir
  • Antwerpen, Belgium
  • +31 more
Aug 16, 2016

Hepatitis C Trial in Chicago (Peginterferon alfa-2a, Ribavirin, telaprevir)

Terminated
Has Results
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 11, 2016

Chronic Hepatitis C Virus (HCV) Infection Trial in Worldwide (Telaprevir, Pegylated interferon alfa-2a, Ribavirin)

Completed
  • Chronic Hepatitis C Virus (HCV) Infection
  • Telaprevir
  • +2 more
  • Linz, Austria
  • +20 more
Jun 29, 2016

Hepatitis C Trial in Worldwide (Telaprevir, Peginterferon alfa-2b, Ribavirin)

Terminated
Has Results
  • Hepatitis C
  • Telaprevir
  • +2 more
  • Phoenix, Arizona
  • +23 more
Jun 7, 2016

Hepatitis C, Chronic Trial in Worldwide (GSK2336805 40 mg, GSK2336805 60 mg, Pegylated interferon alpha-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • GSK2336805 40 mg
  • +4 more
  • Dothan, Alabama
  • +33 more
Apr 25, 2017

Chronic Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated-Interferon-alfa-2a)

Completed
  • Chronic Hepatitis C
  • Telaprevir
  • +2 more
  • Cairns, Australia
  • +31 more
May 4, 2016

Dual And Triple Therapies Based on Peginterferon Alfa in Chronic

Completed
Has Results
  • Hepatitis C, Chronic
  • Peg-IFN Alfa-2a
  • +4 more
  • Antwerpen, Belgium
  • +271 more
Feb 10, 2017

Hepatitis C Trial in Worldwide (Daclatasvir, Telaprevir, Peginterferon alfa-2a)

Completed
Has Results
  • Hepatitis C
  • Birmingham, Alabama
  • +90 more
Apr 28, 2016

Hepatitis C Virus Infection Trial in Japan (Daclatasvir, Asunaprevir, Ribavirin)

Completed
  • Hepatitis C Virus Infection
  • Nagoya-shi, Aichi, Japan
  • +47 more
Sep 23, 2015

Hepatitis C Trial in United States (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

Terminated
Has Results
  • Hepatitis C
  • Telaprevir
  • +2 more
  • Birmingham, Alabama
  • +26 more
Jul 13, 2015